| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Previous Article | Next Article ![]()
Molecular and Cellular Biology, June 2008, p. 3742-3756, Vol. 28, No. 11
0270-7306/08/$08.00+0 doi:10.1128/MCB.01832-07
Copyright © 2008, American Society for Microbiology. All Rights Reserved.

Tanja Milosavljevic,1 and
Suresh K. Alahari1,2*
Department of Biochemistry and Molecular Biology, School of Medicine, LSU Health Science Center, New Orleans, Louisiana 70112,1 Laboratory of Developmental Neurobiology, Rockefeller University, New York, New York2
Received 8 October 2007/ Returned for modification 8 November 2007/ Accepted 2 March 2008
Nischarin is a novel protein that regulates cell migration by inhibiting p21-activated kinase (PAK). LIM kinase (LIMK) is a downstream effector of PAK, and it is known to play an important role in cell invasion. Here we show that nischarin also associates with LIMK to inhibit LIMK activation, cofilin phosphorylation, and LIMK-mediated invasion of breast cancer cells, suggesting that nischarin regulates cell invasion by negative modulation of the LIMK/cofilin pathway. The amino terminus of nischarin binds to the PDZ and kinase domains of LIMK. Although LIMK activation enhances the interaction with nischarin, only phosphorylation of threonine 508 of LIMK is crucial for the interaction. Inhibition of endogenous nischarin expression by RNA interference stimulates breast cancer cell invasion. Also, nischarin small interfering RNA (siRNA) enhances cofilin phosphorylation. In addition, knock-down of nischarin showed branched projection actin structures. Collectively these data indicate that nischarin siRNA may enhance random migration, resulting in stimulation of invasion.
Published ahead of print on 10 March 2008.
Present address: Department of Physiology, School of Medicine, Zhejiang University, Hangzhou, China.
| J. Bacteriol. | J. Virol. | Eukaryot. Cell |
|---|
| Microbiol. Mol. Biol. Rev. | Clin. Vaccine Immunol. | All ASM Journals |
|---|